Israel's Teva Says MS Drug Fails To Achieve Trial Expectations
This article was originally published in PharmAsia News
Executive Summary
Teva Pharmaceutical reported a failure of a multiple sclerosis drug to meet a target in a key trial, but still sees it as a candidate for other purposes